Jaguar Health Inc. (JAGX)
NASDAQ: JAGX
· Real-Time Price · USD
2.19
-0.02 (-0.90%)
At close: Oct 03, 2025, 3:57 PM
2.18
-0.46%
After-hours: Oct 03, 2025, 07:18 PM EDT
-0.90% (1D)
| Bid | 2.15 |
| Market Cap | 4.76M |
| Revenue (ttm) | 11.77M |
| Net Income (ttm) | -40.65M |
| EPS (ttm) | 37.53 |
| PE Ratio (ttm) | 0.06 |
| Forward PE | -3.88 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 2.23 |
| Volume | 58,022 |
| Avg. Volume (20D) | 137,507 |
| Open | 2.21 |
| Previous Close | 2.21 |
| Day's Range | 2.16 - 2.24 |
| 52-Week Range | 1.57 - 33.75 |
| Beta | 0.61 |
| Ex-Dividend Date | n/a |
About JAGX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol JAGX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for JAGX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsJaguar Health Inc. is scheduled to release its earnings on
Nov 12, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-20.08%
Jaguar Health shares are trading lower after the c...
Unlock content with
Pro Subscription
4 months ago
-27.05%
Jaguar Health shares are trading lower after the company announced the pricing of a $1.5 million registered direct offering of 246,306 shares at $6.09 per share.
1 month ago · accessnewswire.com
Jaguar Health Reports Approval of All Proposals at August 2025 Annual Meeting of StockholdersJaguar CEO Lisa Conte presenting August 20 at Emerging Growth Conference to provide updates on near-term catalysts; Click here to register As announced , initial proof-of-concept results from the ongo...
